版本:
中国

Novartis says Entresto linked to higher quality of life scores

ZURICH, Sept 19 Swiss drugmaker Novartis said on Monday that a new analysis showed its Entresto drug was linked to higher quality of life scores among patients who had been hospitalized with reduced ejection fraction heart failure.

"A new post-hoc analysis demonstrates that the decline in health-related quality of life scores... among patients taking Novartis' Entresto was lower - approximately 50 percent less of a decline - compared to those taking ACE inhibitor enalapril," Basel-based Novartis said in a statement. (Reporting by Joshua Franklin)

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐